Correlation Between MACOM Technology and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both MACOM Technology and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MACOM Technology and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MACOM Technology Solutions and Entero Therapeutics,, you can compare the effects of market volatilities on MACOM Technology and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MACOM Technology with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of MACOM Technology and Entero Therapeutics,.
Diversification Opportunities for MACOM Technology and Entero Therapeutics,
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between MACOM and Entero is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding MACOM Technology Solutions and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and MACOM Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MACOM Technology Solutions are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of MACOM Technology i.e., MACOM Technology and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between MACOM Technology and Entero Therapeutics,
Given the investment horizon of 90 days MACOM Technology Solutions is expected to generate 0.24 times more return on investment than Entero Therapeutics,. However, MACOM Technology Solutions is 4.2 times less risky than Entero Therapeutics,. It trades about 0.07 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.06 per unit of risk. If you would invest 6,894 in MACOM Technology Solutions on September 2, 2024 and sell it today you would earn a total of 6,388 from holding MACOM Technology Solutions or generate 92.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
MACOM Technology Solutions vs. Entero Therapeutics,
Performance |
| Timeline |
| MACOM Technology Sol |
| Entero Therapeutics, |
MACOM Technology and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MACOM Technology and Entero Therapeutics,
The main advantage of trading using opposite MACOM Technology and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MACOM Technology position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| MACOM Technology vs. NXP Semiconductors NV | MACOM Technology vs. GSI Technology | MACOM Technology vs. MaxLinear | MACOM Technology vs. Texas Instruments Incorporated |
| Entero Therapeutics, vs. Tff Pharmaceuticals | Entero Therapeutics, vs. Eliem Therapeutics | Entero Therapeutics, vs. Inhibrx | Entero Therapeutics, vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world |